This stock is in Healthcare: revenue rank 184 of 301, share 0.1%.
184 / 3010.1%revenue share
₩2,465+14.39%
2026-10-08 closeDT&CRO's close-price date is 2026-10-08. Trailing 12 months PER is -1.6×. Latest quarter PBR is 3.82×. The comparison sector is Healthcare.
Sector grades
F
Overall: Healthcare 295/308 · top 96%
Factor composite · relative position in sector
Industry structure
KRAs of 2026-10-08Healthcare
Who dominates this industry?
- 1삼성바이오로직스7.2%
- 2셀트리온5.7%
- 3녹십자홀딩스3.5%
- 4유한양행3.3%
- 5대웅3.1%
- 6디티앤씨알오0.1%
Concentration
DistributedCR3 16.4%HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.
Polarization
Winner-take-all deepeningConsistentPolarization measures industry gaps and structure, not valuation, forecast, or investment advice.
Margin lens
- IQR%p
- 31.61
- Direction
- 확대
- Level
- 넓음
- Years
- 7
Value lens
- P90/P10
- 14
- Median P/B
- 1.47
- Level
- 넓음
- n
- 271
Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)
Factual information, not investment advice.
Valuation bands — last annual report
The four key numbers use trailing earnings and the latest quarterly book value when available. These bands use the last annual report, so the values can differ.
PER — · PBR 1.1 — own-history percentile 39/100 · 96/100
Open self-history band
PER39/100
PBR96/100
Factual information · not investment advice
Quantus Signal · live data · not investment advice · Privacy Policy